Literature DB >> 16775319

Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.

David C Tscharke1, Wai-Ping Woo, Isaac G Sakala, John Sidney, Alessandro Sette, Denis J Moss, Jack R Bennink, Gunasegaran Karupiah, Jonathan W Yewdell.   

Abstract

Mouse models of orthopoxvirus disease provide great promise for probing basic questions regarding host responses to this group of pathogens, which includes the causative agents of monkeypox and smallpox. However, some essential tools for their study that are taken for granted with other mouse models are not available for these viruses. Here we map and characterize the initial CD8+ T-cell determinants for poxviruses in H-2d-haplotype mice. CD8+ T cells recognizing these three determinants make up around 40% of the total responses to vaccinia virus during and after resolution of infection. We then use these determinants to test if predicted conservation across orthopoxvirus species matches experimental observation and find an unexpectedly cross-reactive variant peptide encoded by ectromelia (mousepox) virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775319      PMCID: PMC1488955          DOI: 10.1128/JVI.00427-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

Authors:  M K Slifka; J L Whitton
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Bioterrorism: a clear and present danger.

Authors:  H C Lane; J L Montagne; A S Fauci
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

3.  A role for Z-DNA binding in vaccinia virus pathogenesis.

Authors:  Yang-Gyun Kim; Maneesha Muralinath; Teresa Brandt; Matthew Pearcy; Kevin Hauns; Ky Lowenhaupt; Bertram L Jacobs; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

4.  Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome.

Authors:  Chris Upton; Stephanie Slack; Arwen L Hunter; Angelika Ehlers; Rachel L Roper
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: epitope association rate.

Authors:  Guillaume Roy-Proulx; Chantal Baron; Claude Perreault
Journal:  Biol Blood Marrow Transplant       Date:  2005-04       Impact factor: 5.742

6.  Respiratory infection of mice with vaccinia virus.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1967-07       Impact factor: 3.891

7.  Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route.

Authors:  J D Williamson; R W Reith; L J Jeffrey; J R Arrand; M Mackett
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

8.  Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.

Authors:  David C Tscharke; Patrick C Reading; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

9.  Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

Authors:  Igor M Belyakov; Patricia Earl; Amiran Dzutsev; Vladimir A Kuznetsov; Michael Lemon; Linda S Wyatt; James T Snyder; Jeffrey D Ahlers; Genoveffa Franchini; Bernard Moss; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

10.  Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

Authors:  V Bronte; M W Carroll; T J Goletz; M Wang; W W Overwijk; F Marincola; S A Rosenberg; B Moss; N P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  72 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

Authors:  Carla Oseroff; Bjoern Peters; Valerie Pasquetto; Magdalini Moutaftsi; John Sidney; Vijay Panchanathan; David C Tscharke; Bernard Maillere; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

4.  Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.

Authors:  Brice Barefoot; Natalie J Thornburg; Daniel H Barouch; Jae-Sung Yu; Christopher Sample; Robert E Johnston; Hua Xin Liao; Thomas B Kepler; Barton F Haynes; Elizabeth Ramsburg
Journal:  Vaccine       Date:  2008-09-20       Impact factor: 3.641

5.  Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.

Authors:  Ren-Huan Xu; Min Fang; Andres Klein-Szanto; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 6.  Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Authors:  Alessandro Sette; Howard Grey; Carla Oseroff; Bjoern Peters; Magdalini Moutaftsi; Shane Crotty; Erika Assarsson; Jay Greenbaum; Yohan Kim; Ravi Kolla; David Tscharke; David Koelle; R Paul Johnson; Janice Blum; Steven Head; John Sidney
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

7.  Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies.

Authors:  S M Mansour Haeryfar; Heather D Hickman; Kari R Irvine; David C Tscharke; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.

Authors:  Douglas W Grosenbach; Robert Jordan; David S King; Aklile Berhanu; Travis K Warren; Dana L Kirkwood-Watts; Shanthakumar Tyavanagimatt; Ying Tan; Rebecca L Wilson; Kevin F Jones; Dennis E Hruby
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 4.169

9.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.

Authors:  Eric F Tewalt; Jean M Grant; Erica L Granger; Douglas C Palmer; Neal D Heuss; Dale S Gregerson; Nicholas P Restifo; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.